The Selective Pulmonary Vasodilatory Effect of Inhaled DETA/NO, a Novel Nitric Oxide Donor, in ARDS - A Pilot Human Trial

Journal of Critical Care

Volumn 19, Issue 1, 2004, Pages 48-53

  Lam, Chen Fuh ^b   Van Heerden, Peter Vernon ^a   Blott, John ^b   Roberts, Brigit ^b   Ilett, Kenneth F ^b  

^a SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIETHYLENETRIAMINE; DIETHYLENETRIAMINE NITRIC OXIDE; NITRIC OXIDE; UNCLASSIFIED DRUG;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; CLINICAL TRIAL; ENDOTRACHEAL TUBE; GAS EXCHANGE; HEMODYNAMIC MONITORING; HUMAN; INHALATION; LUNG FUNCTION; MALE; PHASE 1 CLINICAL TRIAL; TREATMENT OUTCOME; VASODILATATION;

EID: 1942442912     PISSN: 08839441     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrc.2004.02.009     Document Type: Article

References (17)

1. Keefer L, Nims RW, Davies KM, et al: NONOates (1-substituted Diazen-1-ium-1,2-diolates) as nitric oxide donors; convenient nitric oxide dosage forms. Methods Enzymol 268:281-293, 1996
2. Jacobs BR, Brilli RJ, Ballard ET, et al: Aerosolized soluble nitric oxide donor improves oxygenation and pulmonary hypertension in acute lung injury. Am J Respir Crit Care Med 158:1536-1542, 1998
3. Hampl V, Tristani-Firouzi M, Hutsell TC, et al: Nebulized nitric oxide/nucleophile adduct reduces chronic pulmonary hypertension. Cardiovasc Res 31:55-62, 1996
4. Lam CF, van Heerden PV, Ilett KF, et al: Two Aerosolized nitric oxide adducts as selective pulmonary vasodilators for acute pulmonary hypertension. Chest 123:869-874, 2003
5. Mooradian DL, Hutsell TC, Keefer LK: Nitric oxide (NO) donor molecules: effect of NO release rate on vascular smooth muscle cell proliferation in vitro. J Cardiovasc Pharmacol 25:674-678, 1995
6. Lam CF, Caterina P, Filion F, et al: The safety of aerosolized diethylenetriamine nitric oxide adduct after single-dose administration to anesthetised piglets and multiple-dose administration to conscious rats. Toxicol Appl Pharmacol 190: 65-71, 2003
7. Bernard GR, Artigas A, Brigham KL, et al: The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 149:818-824, 1994
8. Giovannoni G, Land JM, Keir G, et al: Adaptation of the nitric reductase and Griess reaction methods for the measurement of serum nitrate plus nitrite levels. Ann Clin Biochem 34:193-198, 1997
9. Ellis G, Adatia I, Yazdanpanah M, et al: Nitrite and Nitrate Analyses: A Clinical Biochemistry Perspective. Clin Biochem 31:195-220, 1998
10. Verdon CP, Burton BA, Prior RL: Sample Pretreatment with Nitrate Reductase and Glucose-6-Phosphate Dehydrogenase Quantitatively Reduces Nitrate While Avoiding Interference by NADP When the Griess Reaction is Used to Assay for Nitrite. Anal Biochem 224:502-508, 1995
11. Lam CF, van Heerden PV, Sviri S, et al: The effects of inhalation of a novel nitric oxide donor, DETA/NO, in a patient with severe hypoxaemia due to acute respiratory distress syndrome. Anaesth Intensive Care 30:472-476, 2002
12. Thebaud B, Arnal JF, Mercier JC, et al: Inhaled and exhaled nitric oxide. Cell Mol Life Sci 55:1103-1112, 1999
13. Lam CF, Sviri S, Ilett KF, et al: Inhaled diazeniumdiolates (NONOates) as selective pulmonary vasodilators. Expert Opinion Investig Drugs 11:897-909, 2002
14. Dukelow AM, Weicker S, Karachi TA, et al: Effects of nebulized diethylenetriamine-NONOate in a mouse model of acute Pseudomonas aeroginosa pneumonia. Chest 122:2127-2136, 2002
15. Lam CF, Lan RS, van Heerden PV, et al: Diethylenetriamine nitric oxide adduct relaxes precontracted mouse tracheal smooth muscle. Clin Exp Pharmacol Physiol 30:709-711, 2003
16. Spack L, Havens PL, Griffith OW: Measurements of total plasma nitrite and nitrate in pediatric patients with the systemic inflammatory response syndrome. Critical Care Med 25:1071-1078, 1997
17. Endo S, Inada K, Takakuwa T, et al: Nitrite/nitrate (NOx) and sFas antigen levels in patients with multiple organ failure. Res Commun Mol Pathol Pharmacol 92:253-256, 1996